Gabapentin enacarbil (XP-13512) is a prodrug of gabapentin which is an anticonvulsant and analgesic drug. It was designed for increased orally bioavailable bioavailability over gabapentin, and human trials showed it to produce extended release of gabapentin with almost twice the overall bioavailability, especially when taken with a fatty meal. Gabapentin enacarbil has passed human clinical trials for the treatment of restless legs syndrome, and initial results have shown it to be well tolerated and reasonably effective.

纯度：≥98%

CAS：478296-72-9